Oxford Biomedica reports 10% constant-currency H1 revenue growth
Oxford Biomedica reported 10% constant-currency revenue growth in H126 to £80.2m, supported by manufacturing and development services demand.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.